¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"case analysis"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
gas analysis
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
imported case
¼öÀÔÁõ·Ê
index case
1. ÃÖÃÊȯÀÚ 2. ÁöÇ¥Áõ·Ê, ÁöÇ¥»ç·Ê
progressive case
ÁøÇ༺¿¹
antigen analysis
Ç׿øºÐ¼®
arterial blood gas analysis
µ¿¸ÆÇ÷°¡½ººÐ¼®
activation analysis
Ȱ¼ºÈºÐ¼®, ¹æ»çȺм®
age-period cohort analysis
¿¬·É±â°£ÄÚȣƮºÐ¼®
analysis
ºÐ¼®
birth cohort analysis
Ãâ»ýÄÚȣƮºÐ¼®
clinical decision analysis
ÀÓ»óÀÇ»ç°áÁ¤ºÐ¼®
clonal analysis
Ŭ·ÐºÐ¼®
cluster analysis
¹«¸®ºÐ¼®
cohort analysis
ÄÚȣƮºÐ¼®
computer-assisted semen analysis
ÄÄÇ»ÅÍÁ¤¾×°Ë»ç
computerized image analysis
ÄÄÇ»ÅÍ¿µ»óºÐ¼®
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
1
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
self-analysis
ÀÚ±âºÐ¼®
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
case-control study
(¢¡retrospective) ÈÄÇ⿬±¸, µÞ¹æÇ⿬±¸
collateral case
ºÎ¼öÀû»ç·Ê
imported case
¼öÀÔÁõ·Ê
index case
ÃʹßȯÀÚ, ÁöÇ¥Áõ·Ê
progressive case
ÁøÇ༺¿¹
analysis
ºÐ¼®
activation analysis
Ȱ¼ºÈºÐ¼®, ¹æ»çȺм®
age-period cohort analysis
¿¬·É±â°£ÄÚȣƮºÐ¼®
antigen analysis
Ç׿øºÐ¼®
birth cohort analysis
Ãâ»ýÄÚȣƮºÐ¼®
clinical decision analysis
ÀÓ»óÀÇ»ç°áÁ¤ºÐ¼®
clonal analysis
Ŭ·ÐºÐ¼®
cluster analysis
¹«¸®ºÐ¼®
cohort analysis
ÄÚȣƮºÐ¼®
computer-assisted semen analysis
ÄÄÇ»ÅÍÁ¤¾×°Ë»ç
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
gasometric analysis
±âüÁ¤·®ºÐ¼®.
gastric analysis
À§¾×°Ë»ç(¡ËþÞÛ).
gene analysis
À¯ÀüÀںм®(¡ÝÂà°).
gene analysis
À¯ÀüÀںм®.
gravimetric analysis
Áß·®ºÐ¼®(ñìÕáÝÂà°).
gravimetric analysis
Áß·®ºÐ¼®
image analysis
¿µ»ó ºÐ¼®
immunochemical analysis
¸é¿ªÈÇÐÀû ºÐ¼®
immunofixation analysis
¸é¿ª°íÁ¤ºÐ¼®
immunoglobulin subgroup analysis
¸é¿ª±Û·ÎºÒ¸°¾ÆÇüºÐ¼®
indirect analysis
°£Á¢ºÐ¼®.
infrared spectroscopic analysis
Àû¿Ü¼± ºÐ±¤ ºÐ¼®
inorganic analysis
¹«±âºÐ¼®(¡ÝÂà°).
plasma analysis
Ç÷ÀåºÐ¼®
polarimetric analysis
Æí±¤ºÐ¼®(ÊÙËÓËÛ).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
case morbidity rate
Áõ·ÊÀÌȯÀ²(Ì¡ËçËöÌ·Ëô).
case payment system
Æ÷°ý¼ö°¡Á¦
case presentation
Áõ·ÊÁ¦½Ã(Áõ¿¹Á¦½Ã).
case presentation
Áõ·ÊÁ¦½Ã(ñøçÓð«ãÆ).
case report
Áõ·Êº¸°í(Áõ¿¹º¸°í).
case report
Áõ·Êº¸°í(ñøçÓÜÃͱ).
case study
Áõ·Ê¿¬±¸(Áõ¿¹¿¬±¸).
case study
Áõ·Ê¿¬±¸(ñøçÓæÚϼ).
nested case control study
progressive case
ÁøÇ༺ ¿¹.
activation analysis
¹æ»çȺм®, Ȱ¼ºÈºÐ¼®
activation analysis
Ȱ¼ºÈºÐ¼®(¡ÝÂà°), ¹æ»çÈ(Û¯ÞÒûù)ºÐ¼®.
amniotic fluid analysis
¾ç¼öºÐ¼®
analysis
ºÐ¼®
analysis of variance technique
ºÐ»ê±â¼úºÐ¼®
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½